Kewaunee Scientific Co. (NASDAQ:KEQU) Shares Purchased by JPMorgan Chase & Co.

JPMorgan Chase & Co. raised its position in Kewaunee Scientific Co. (NASDAQ:KEQU) by 18,000.0% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 905 shares of the technology company’s stock after purchasing an additional 900 shares during the period. JPMorgan Chase & Co.’s holdings in Kewaunee Scientific were worth $30,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of KEQU. Dimensional Fund Advisors LP raised its holdings in Kewaunee Scientific by 3.6% in the second quarter. Dimensional Fund Advisors LP now owns 177,548 shares of the technology company’s stock valued at $8,378,000 after buying an additional 6,132 shares during the period. De Lisle Partners LLP grew its position in Kewaunee Scientific by 36.6% in the 3rd quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company’s stock valued at $1,446,000 after buying an additional 11,511 shares in the last quarter. Geode Capital Management LLC boosted its stake in Kewaunee Scientific by 8.9% during the third quarter. Geode Capital Management LLC now owns 23,784 shares of the technology company’s stock valued at $792,000 after buying an additional 1,941 shares in the last quarter. Ritholtz Wealth Management lifted its position in shares of Kewaunee Scientific by 24.6% during the 3rd quarter. Ritholtz Wealth Management now owns 10,913 shares of the technology company’s stock valued at $363,000 after acquiring an additional 2,156 shares during the last quarter. Finally, State Street Corp purchased a new stake in shares of Kewaunee Scientific in the third quarter valued at $266,000. 32.69% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Kewaunee Scientific

In other news, VP Douglas J. Batdorff sold 3,470 shares of the stock in a transaction dated Monday, December 30th. The shares were sold at an average price of $65.50, for a total transaction of $227,285.00. Following the transaction, the vice president now owns 5,000 shares of the company’s stock, valued at $327,500. This represents a 40.97 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Donald T. Gardner III sold 1,257 shares of Kewaunee Scientific stock in a transaction dated Friday, January 10th. The shares were sold at an average price of $59.26, for a total transaction of $74,489.82. Following the transaction, the chief financial officer now owns 21,358 shares of the company’s stock, valued at $1,265,675.08. This represents a 5.56 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 11,994 shares of company stock valued at $729,430. 14.20% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Separately, StockNews.com upgraded shares of Kewaunee Scientific from a “hold” rating to a “buy” rating in a research note on Wednesday, December 18th.

Kewaunee Scientific Stock Up 3.4 %

Shares of Kewaunee Scientific stock opened at $64.26 on Wednesday. The company has a debt-to-equity ratio of 0.45, a current ratio of 2.64 and a quick ratio of 2.13. The company has a market capitalization of $184.55 million, a P/E ratio of 10.18 and a beta of 0.71. The business has a 50-day moving average of $55.42 and a two-hundred day moving average of $46.63. Kewaunee Scientific Co. has a 1 year low of $27.00 and a 1 year high of $67.20.

Kewaunee Scientific (NASDAQ:KEQU) last posted its quarterly earnings results on Wednesday, December 11th. The technology company reported $1.41 EPS for the quarter. Kewaunee Scientific had a return on equity of 25.83% and a net margin of 9.39%.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.